The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver disorders worldwide. It is associated with clinical states such as obesity, insulin resistance, and type 2 diabetes, and covers a wide range of liver changes, ranging from simple steatosis to non-alcoholic steatohepatitis (NASH), liver cirrhosis, and hepatocellular carcinoma. Metabolic disorders, such as lipid accumulation, insulin resistance, and inflammation, have been implicated in the pathogenesis of NAFLD, but the underlying mechanisms, including those that drive disease progression, are not fully understood. Both innate and recruited immune cells mediate the development of insulin resistance and NASH. Therefore, modifying the polarization of resident and recruited macrophage/Kupffer cells is expected to lead to new therapeutic strategies in NAFLD. Oxidative stress is also pivotal for the progression of NASH, which has generated interest in carotenoids as potent micronutrient antioxidants in the treatment of NAFLD. In addition to their antioxidative function, carotenoids regulate macrophage/Kupffer cell polarization and thereby prevent NASH progression. In this review, we summarize the molecular mechanisms involved in the pathogenesis of NAFLD, including macrophage/Kupffer cell polarization, and disturbed hepatic function in NAFLD. We also discuss dietary antioxidants, such as β-cryptoxanthin and astaxanthin, that may be effective in the prevention or treatment of NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Armstrong, M. J., Gaunt, P., Aithal, G. P., Barton, D., Hull, D., Parker, R., Hazlehurst, J. M., Guo, K., Abouda, G., Aldersley, M. A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00803-x · Cited by 2,203
Williams, C. D., Stengel, J., Asike, M. I., Torres, D. M., Shaw, J., Contreras, M., Landt, C. L., & Harrison, S. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.09.038 · Cited by 2,148
Ambati, R., Phang, S.-M., Ravi, S., & Aswathanarayana, R. (2014) · Marine Drugs · doi:10.3390/md12010128 · Cited by 1,974
Association of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli-Labate, A. M., Bianchi, G., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,568
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
Weisberg, S. P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R. L., & Jr., A. W. F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24335 · Cited by 1,497
Haematococcus astaxanthin: applications for human health and nutrition
Guerin, M., Huntley, M. E., & Olaizola, M. (2003) · Trends in Biotechnology · doi:10.1016/s0167-7799(03)00078-7 · Cited by 1,495
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
Weisberg, S. P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24335c1 · Cited by 1,425
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317797 · Cited by 1,298
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17797 · Cited by 1,296
Lavine, J. E. (2011) · JAMA · doi:10.1001/jama.2011.520 · Cited by 1,101
Kamei, N., Tobe, K., Suzuki, R., Ohsugi, M., Watanabe, T., Kubota, N., Ohtsuka-Kowatari, N., Kumagai, K., Sakamoto, K., Kobayashi, M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601284200 · Cited by 917
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Red Eagle, A., Vats, D., Morel, C. R., Goforth, M. H., Subramanian, V., Mukundan, L., Ferrante, A. W., & Chawla, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.04.003 · Cited by 847
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
Lassailly, G., Caiazzo, R., Buob, D., Pigeyre, M., Verkindt, H., Labreuche, J., Raverdy, V., Leteurtre, E., Dharancy, S., Louvet, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.014 · Cited by 762
Wu, H., Ghosh, S., Perrard, X. D., Feng, L., Garcia, G. E., Perrard, J. L., Sweeney, J. F., Peterson, L. E., Chan, L., Smith, C. W., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.638379 · Cited by 680
Kaulmann, A., & Bohn, T. (2014) · Nutrition Research · doi:10.1016/j.nutres.2014.07.010 · Cited by 664
Haukeland, J. W., Damås, J. K., Konopski, Z., Løberg, E. M., Haaland, T., Goverud, I., Torjesen, P. A., Birkeland, K., Bjøro, K., & Aukrust, P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.02.011 · Cited by 603
Adipose tissue as a source of hormones
Siiteri, P. K. (1987) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/45.1.277 · Cited by 599
A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2010) · Hepatology · doi:10.1002/hep.23623 · Cited by 564
Wan, J., Benkdane, M., Teixeira-Clerc, F., Bonnafous, S., Louvet, A., Lafdil, F., Pecker, F., Tran, A., Gual, P., Mallat, A., et al. (2014) · Hepatology · doi:10.1002/hep.26607 · Cited by 558
Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study
Martínez-González, M. Á., Fuente-Arrillaga, C. D. L., Nunez-Cordoba, J. M., Basterra-Gortari, F. J., Beunza, J. J., Vazquez, Z., Benito, S., Tortosa, A., & Bes-Rastrollo, M. (2008) · BMJ · doi:10.1136/bmj.39561.501007.be · Cited by 517
Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet
Matsuzawa, N., Takamura, T., Kurita, S., Misu, H., Ota, T., Ando, H., Yokoyama, M., Honda, M., Zen, Y., Nakanuma, Y., et al. (2007) · Hepatology · doi:10.1002/hep.21874 · Cited by 515
Self-citationHepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2
Miura, K., Yang, L., van Rooijen, N., Ohnishi, H., & Seki, E. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00365.2011 · Cited by 503
Tuning inflammation and immunity by chemokine sequestration: decoys and more
Mantovani, A., Bonecchi, R., & Locati, M. (2006) · Nature Reviews Immunology · doi:10.1038/nri1964 · Cited by 481
Loomba, R., Abraham, M., Unalp, A., Wilson, L., Lavine, J., Doo, E., & Bass, N. M. (2012) · Hepatology · doi:10.1002/hep.25772 · Cited by 481
Natural history of nonalcoholic steatohepatitis: A longitudinal study of repeat liver biopsies
Fassio, E., �lvarez, E., Dom�nguez, N., Landeira, G., & Longo, C. (2004) · Hepatology · doi:10.1002/hep.20410 · Cited by 469
CCR1 and CCR5 promote hepatic fibrosis in mice
Seki, E., De Minicis, S., Gwak, G.-Y., Kluwe, J., Inokuchi, S., Bursill, C. A., Llovet, J. M., Brenner, D. A., & Schwabe, R. F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37444 · Cited by 431
Macrophage Plasticity and Polarization in Liver Homeostasis and Pathology
Sica, A., Invernizzi, P., & Mantovani, A. (2014) · Hepatology · doi:10.1002/hep.26754 · Cited by 422
CCR2 promotes hepatic fibrosis in mice #
Seki, E., de Minicis, S., Inokuchi, S., Taura, K., Miyai, K., van Rooijen, N., Schwabe, R. F., & Brenner, D. A. (2009) · Hepatology · doi:10.1002/hep.22952 · Cited by 416
Bugianesi, E., Pagotto, U., Manini, R., Vanni, E., Gastaldelli, A., de Iasio, R., Gentilcore, E., Natale, S., Cassader, M., Rizzetto, M., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2240 · Cited by 408
Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
Haas, J. T., Francque, S., & Staels, B. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105331 · Cited by 394
Impact of micronutrient deficiencies on obesity
García, O. P., Long, K. Z., & Rosado, J. L. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00228.x · Cited by 373
Role of cytokines and chemokines in non-alcoholic fatty liver disease
Braunersreuther, V. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i8.727 · Cited by 362
Klein, I., Cornejo, J. C., Polakos, N. K., John, B., Wuensch, S. A., Topham, D. J., Pierce, R. H., & Crispe, I. N. (2007) · Blood · doi:10.1182/blood-2007-02-073841 · Cited by 330
Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
Ahmed, A., Wong, R. J., & Harrison, S. A. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.029 · Cited by 327
Yatsuji, S., Hashimoto, E., Tobari, M., Taniai, M., Tokushige, K., & Shiratori, K. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05640.x · Cited by 318
Obstfeld, A. E., Sugaru, E., Thearle, M., Francisco, A.-M., Gayet, C., Ginsberg, H. N., Ables, E. V., & Ferrante, A. W. (2010) · Diabetes · doi:10.2337/db09-1403 · Cited by 314
Update on the Biological Characteristics of the Antioxidant Micronutrients
ROCK, C. L., JACOB, R. A., & BOWEN, P. E. (1996) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(96)00190-3 · Cited by 308
Kitade, H., Sawamoto, K., Nagashimada, M., Inoue, H., Yamamoto, Y., Sai, Y., Takamura, T., Yamamoto, H., Miyamoto, K.-I., Ginsberg, H. N., et al. (2012) · Diabetes · doi:10.2337/db11-1506 · Cited by 292
Self-citationA concise review of non-alcoholic fatty liver disease
Than, N. N., & Newsome, P. N. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.001 · Cited by 287
Dietary habits and nutrient intake in non-alcoholic steatohepatitis
Toshimitsu, K., Matsuura, B., Ohkubo, I., Niiya, T., Furukawa, S., Hiasa, Y., Kawamura, M., Ebihara, K., & Onji, M. (2007) · Nutrition · doi:10.1016/j.nut.2006.09.004 · Cited by 264
Current efforts and trends in the treatment of NASH
Ratziu, V., Goodman, Z., & Sanyal, A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.041 · Cited by 262
Louvet, A., Teixeira-Clerc, F., Chobert, M.-N., Deveaux, V., Pavoine, C., Zimmer, A., Pecker, F., Mallat, A., & Lotersztajn, S. (2011) · Hepatology · doi:10.1002/hep.24524 · Cited by 261
Ni, Y., Nagashimada, M., Zhuge, F., Zhan, L., Nagata, N., Tsutsui, A., Nakanuma, Y., Kaneko, S., & Ota, T. (2015) · Scientific Reports · doi:10.1038/srep17192 · Cited by 261
Self-citationPlasma adiponectin is decreased in nonalcoholic fatty liver disease
Pagano, C., Soardo, G., Esposito, W., Fallo, F., Basan, L., Donnini, D., Federspil, G., Sechi, L. A., & Vettor, R. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01821 · Cited by 256
Inouye, K. E., Shi, H., Howard, J. K., Daly, C. H., Lord, G. M., Rollins, B. J., & Flier, J. S. (2007) · Diabetes · doi:10.2337/db07-0425 · Cited by 252 · cited 2×
“However, there are also studies reporting conflicting results, showing that MCP-1-deficient mice do not exhibit reduced macrophage infiltration or improved insulin sensitivity, which suggests that MCP-1-CCR2 signaling is not critical for obesity-induced macrophage recruitment or systemic insulin resistance [55,56].”
ResultNon Alcoholic Fatty Liver: Epidemiology and Natural History
Masarone, M., Federico, A., Abenavoli, L., Loguercio, C., & Persico, M. (2015) · Reviews on Recent Clinical Trials · doi:10.2174/1574887109666141216111143 · Cited by 247
Insulin Resistance Accelerates a Dietary Rat Model of Nonalcoholic Steatohepatitis
Ota, T., Takamura, T., Kurita, S., Matsuzawa, N., Kita, Y., Uno, M., Akahori, H., Misu, H., Sakurai, M., Zen, Y., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.10.014 · Cited by 227
Self-citationEffects of astaxanthin in obese mice fed a high-fat diet
IKEUCHI, M., KOYAMA, T., TAKAHASHI, J., & YAZAWA, K. (2007) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.60521 · Cited by 222
Velussi, M., Cernigoi, A. M., Ariella, D. M., Dapas, F., Caffau, C., & Zilli, M. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80255-3 · Cited by 216
Sofi, F., Macchi, C., Abbate, R., Gensini, G. F., & Casini, A. (2013) · BioFactors · doi:10.1002/biof.1096 · Cited by 213
Jornayvaz, F. R., Jurczak, M. J., Lee, H.-Y., Birkenfeld, A. L., Frederick, D. W., Zhang, D., Zhang, X.-M., Samuel, V. T., & Shulman, G. I. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00361.2010 · Cited by 211
Current concepts in the pathogenesis of nonalcoholic fatty liver disease
Méndez‐Sánchez, N., Arrese, M., Zamora‐Valdés, D., & Uribe, M. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01483.x · Cited by 184
Romaguera, D., Norat, T., Mouw, T., May, A. M., Bamia, C., Slimani, N., Travier, N., Besson, H., Luan, J., Wareham, N., et al. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.108902 · Cited by 183
Antifibrotic Effects of CXCL9 and Its Receptor CXCR3 in Livers of Mice and Humans
Wasmuth, H. E., Lammert, F., Zaldivar, M. M., Weiskirchen, R., Hellerbrand, C., Scholten, D., Berres, M.-L., Zimmermann, H., Streetz, K. L., Tacke, F., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.03.053 · Cited by 168
YOUNOSSI, Z. M. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03710.x · Cited by 166
Wang, Y., Ausman, L. M., Greenberg, A. S., Russell, R. M., & Wang, X. (2009) · International Journal of Cancer · doi:10.1002/ijc.24689 · Cited by 166
Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes
Lomonaco, R., Bril, F., Portillo-Sánchez, P., Ortiz‐Lopez, C., Orsak, B., Biernacki, D., Lo, M. C., Suman, A., Weber, M. H., & Cusi, K. J. (2016) · Diabetes Care · doi:10.2337/dc15-1876 · Cited by 160
Metabolic aspects of adult patients with nonalcoholic fatty liver disease
Abenavoli, L., Milic, N., Di Renzo, L., Preveden, T., Medić-Stojanoska, M., & De Lorenzo, A. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i31.7006 · Cited by 158
Kirk, E. A., Sagawa, Z. K., McDonald, T. O., O'Brien, K. D., & Heinecke, J. W. (2008) · Diabetes · doi:10.2337/db07-1061 · Cited by 149
Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet
Machado, M. V., & Cortez‐Pinto, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040481 · Cited by 142
Erhardt, A., Stahl, W., Sies, H., Lirussi, F., Donner, A., & Häussinger, D. (2011) · European journal of medical research · doi:10.1186/2047-783x-16-2-76 · Cited by 140
Inhibition of CCR2 Ameliorates Insulin Resistance and Hepatic Steatosis in db/db Mice
Tamura, Y., Sugimoto, M., Murayama, T., Ueda, Y., Kanamori, H., Ono, K., Ariyasu, H., Akamizu, T., Kita, T., Yokode, M., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.168633 · Cited by 137
Silymarin in non alcoholic fatty liver disease
Cacciapuoti, F. (2013) · World Journal of Hepatology · doi:10.4254/wjh.v5.i3.109 · Cited by 134
Yadav, D. K. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04399-x · Cited by 132
Distinct development and functions of resident and recruited liver Kupffer cells/macrophages
Ikarashi, M., Nakashima, H., Kinoshita, M., Sato, A., Nakashima, M., Miyazaki, H., Nishiyama, K., Yamamoto, J., & Seki, S. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0313144 · Cited by 132
NAFLD, Obesity, and Bariatric Surgery
Angulo, P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.041 · Cited by 124
Haegele, A. D., Gillette, C. D., O'Neill, C., Wolfe, P., Heimendinger, J., SEDLACEK, S. M., & Thompson, H. J. (2000) · PubMed · Cited by 123
Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis.
Bahçecioğlu, İ. H., Yalnız, M., Ataseven, H., İlhan, A., Özercan, İ. H., Seçkin, D., & Şahin, K. (2005) · PubMed · Cited by 111
Yang, Y. J., Kim, B., Park, Y., Koo, S. I., & Lee, J. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.10.014 · Cited by 110
Ruhl, C. E., & Everhart, J. E. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00395-0 · Cited by 107
Ni, Y., Nagashimada, M., Zhan, L., Nagata, N., Kobori, M., Sugiura, M., Ogawa, K., Kaneko, S., & Ota, T. (2015) · Endocrinology · doi:10.1210/en.2014-1776 · Cited by 104
Self-citationCarotenoids and non-alcoholic fatty liver disease.
Yılmaz, B., Şahin, K., Bilen, H., Bahçecioğlu, İ. H., Bilir, B., Ashraf, S., Halazun, K. J., & Küçük, Ö. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2304-3881.2015.01.11 · Cited by 98
Kang, J.-O., Kim, S.-J., & Kim, H. (2001) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2001.23.2.627931 · Cited by 93
Liver innate immune cells and insulin resistance: the multiple facets of Kupffer cells
Jager, J., Aparicio‐Vergara, M., & Aouadi, M. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12483 · Cited by 90
Sugiura, M., Nakamura, M., Ikoma, Y., Yano, M., Ogawa, K., Matsumoto, H., Kato, M., Ohshima, M., & Nagao, A. (2006) · Journal of Epidemiology · doi:10.2188/jea.16.71 · Cited by 86
Impact of Divergent Effects of Astaxanthin on Insulin Signaling in L6 Cells
Ishiki, M., Nishida, Y., Ishibashi, H., Wada, T., Fujisaka, S., Takikawa, A., Urakaze, M., Sasaoka, T., Usui, I., & Tobe, K. (2013) · Endocrinology · doi:10.1210/en.2012-2198 · Cited by 86
Takayanagi, K., Morimoto, S.-I., Shirakura, Y., Mukai, K., Sugiyama, T., Tokuji, Y., & Ohnishi, M. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf202821u · Cited by 79
Kobori, M., Ni, Y., Takahashi, Y., Watanabe, N., Sugiura, M., Ogawa, K., Nagashimada, M., Kaneko, S., Naito, S., & Ota, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098294 · Cited by 77
Self-citationGunanti, I. R., Marks, G. C., Mamun, A. A., & Long, K. Z. (2014) · Journal of Nutrition · doi:10.3945/jn.113.183137 · Cited by 77
Hajiaghamohammadi, A. A., Ziaee, A., & Samimi, R. (2012) · Phytotherapy Research · doi:10.1002/ptr.3728 · Cited by 76
Katsuura, S., Imamura, T., Bando, N., & Yamanishi, R. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800566 · Cited by 76
Bahçecioğlu, İ. H., Kuzu, N., Metin, K., Özercan, İ. H., Üstündağ, B., Şahin, K., & Küçük, Ö. (2010) · Veterinary Medicine International · doi:10.4061/2010/262179 · Cited by 75
Management of nonalcoholic fatty liver disease: An evidence-based clinical practice review
Arab, J. P., Candia, R., Zapata, R., Muñoz, C., Arancibia, J. P., Poniachik, J., Soza, A., Fuster, F., Brahm, J., Sanhueza, E., et al. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i34.12182 · Cited by 71
Sugiura, M., Nakamura, M., Ikoma, Y., Yano, M., Ogawa, K., Matsumoto, H., Kato, M., Ohshima, M., & Nagao, A. (2005) · Journal of Epidemiology · doi:10.2188/jea.15.180 · Cited by 67
Astaxanthin prevents and reverses the activation of mouse primary hepatic stellate cells
Yang, Y. J., Bae, M., Kim, B., Park, Y., Koo, S. I., & Lee, J. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.11.005 · Cited by 54
Kirovski, G., Gäbele, E., Dorn, C., Moleda, L., Niessen, C., Weiß, T. S., Wobser, H., Schacherer, D., Buechler, C., Wasmuth, H. E., et al. (2010) · PubMed · doi:10.5283/epub.37048 · Cited by 53
Clinical features of nonalcoholic steatohepatitis in Japan: evidence from the literature
Ono, M., & Saibara, T. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-006-1876-0 · Cited by 49
Sugiura, M., Nakamura, M., Ogawa, K., Ikoma, Y., Matsumoto, H., Ando, F., Shimokata, H., & Yano, M. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509382124 · Cited by 46
Vitamin B12 and omega-3 fatty acids together regulate lipid metabolism in Wistar rats
Khaire, A. A., Rathod, R. S., Kale, A. A., & Joshi, S. (2015) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2015.04.006 · Cited by 39
Mohammadi, A. A. H., Amir, Z., & Rafiei, R. (2008) · Hepatitis Monthly · Cited by 37
Common Features of the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease
Almeda‐Valdés, P., Aguilar-Olivos, N. E., Uribe, M., et al. (2015) · Reviews on Recent Clinical Trials · doi:10.2174/1574887109666141216103908 · Cited by 35
Nießen, C. (2012) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.26531 · Cited by 31
Camps, J., & Joven, J. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0762 · Cited by 4
Cited by
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
Ipsen, D. H., Lykkesfeldt, J., & Tveden-Nyborg, P. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2860-6 · Cited by 1,471
NAFLD as a Continuum: From Obesity to Metabolic Syndrome and Diabetes
Godoy-Matos, A. F., Silva Júnior, W. S., & Valerio, C. M. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00570-y · Cited by 643
Tanase, D. M., Gosav, E. M., Costea, C. F., Ciocoiu, M., Lacatusu, C. M., Maranduca, M. A., Ouatu, A., & Floria, M. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3920196 · Cited by 627
FGF21 gene therapy as treatment for obesity and insulin resistance
Jimenez, V., Jambrina, C., Casana, E., Sacristan, V., Muñoz, S., Darriba, S., Rodó, J., Mallol, C., Garcia, M., León, X., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708791 · Cited by 324
Role of c-Jun N-terminal Kinase (JNK) in Obesity and Type 2 Diabetes
Yung, J. H. M., & Giacca, A. (2020) · Cells · doi:10.3390/cells9030706 · Cited by 263
Metadata
- Authors
- Kitade, H., Chen, G., Ni, Y., & Ota, T.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2017-04-14
- Volume
- 9
- Issue
- 4
- Pages
- 387
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2605866155
- Cited by
- 492
- References
- 107
- FWCI
- 32.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.